Technical and Target Lesion Failure in Calcified Coronary Lesions

BACKGROUND: Intravascular lithotripsy (IVL) has been demonstrated effective and safe in the treatment of balloon-crossable calcified coronary lesions. However, a significant subset of patients still experiences suboptimal technical results and subsequent target lesion failure (TLF), leaving a gap in our understanding of procedural success drivers. OBJECTIVES: This study sought to identify factors independently associated with technical failure and 12-month TLF in calcified coronary lesions treated with IVL-assisted percutaneous coronary intervention. METHODS: From the multicenter BENELUX-IVL registry (NCT06577038), we included patients with complete quantitative coronary analysis. The primary technical endpoint was technical failure (unsuccessful IVL delivery, residual stenosis >30%, or procedural complications). The primary clinical endpoint was 12-month TLF (cardiac death, target-vessel myocardial infarction, or ischemia-driven revascularization). RESULTS: A total of 571 patients (including 595 target lesions) were included. Technical failure occurred in 60 (10.5%) of the lesions, whereas 12-month TLF was reported in 41 (7.2%) cases. Multivariable analysis identified multivessel disease (OR: 1.39; 95% CI: 1.02-1.90), in-stent lesions (OR: 1.94; 95% CI: 1.14-3.30), and the absence of intravascular imaging (OR: 1.95; 95% CI: 1.13-3.40) as independent determinants of technical failure. Left circumflex (HR: 2.97; 95% CI: 1.49-5.92), in-stent target lesions (HR: 2.01; 95% CI: 1.02-3.52), technical failure (HR: 2.42; 95% CI: 1.26-4.61), diabetes mellitus (HR: 2.35; 95% CI: 1.23-4.47), reduced estimated glomerular filtration rate (HR: 0.98; 95% CI: 0.97-0.99), and younger age (HR: 0.95; 95% CI: 0.92-0.98) emerged as factors independently associated with TLF. CONCLUSIONS: Our findings demonstrate that residual risk in IVL-assisted percutaneous coronary intervention is driven by a distinct interplay of modifiable and nonmodifiable factors, rather than inherent limitations of the technology itself.

Authors

Institutions

Publication Details

Journal
JACC Advances
Published
2026-07-16
DOI
https://doi.org/10.1016/j.jacadv.2026.103010
Primary Topic
Coronary Interventions and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Technical and Target Lesion Failure in Calcified Coronary Lesions

Bimmer E.P.M. Claessen, Martijn J. H. van Oort, Maria Mouratidou, Gianluca Mincione et al.
JACC Advances
Coronary Interventions and Diagnostics
article

Technical and Target Lesion Failure in Calcified Coronary Lesions

Bimmer E.P.M. Claessen, Martijn J. H. van Oort, Maria Mouratidou, Gianluca Mincione, Μarios Sagris, Federico Oliveri, F Kley, Jose Montero-Cabezas, V Paradies, J Kefer, I Al Amri, Brian O. Bingen, Alessandro Mandurino-Mirizzi, J. Wouter Jukema, Akshay Phagu, Aukelien C. Dimitriu-Leen, Ioannis Karalis, Tessel Vossenberg
article en

Abstract

BACKGROUND: Intravascular lithotripsy (IVL) has been demonstrated effective and safe in the treatment of balloon-crossable calcified coronary lesions. However, a significant subset of patients still experiences suboptimal technical results and subsequent target lesion failure (TLF), leaving a gap in our understanding of procedural success drivers. OBJECTIVES: This study sought to identify factors independently associated with technical failure and 12-month TLF in calcified coronary lesions treated with IVL-assisted percutaneous coronary intervention. METHODS: From the multicenter BENELUX-IVL registry (NCT06577038), we included patients with complete quantitative coronary analysis. The primary technical endpoint was technical failure (unsuccessful IVL delivery, residual stenosis >30%, or procedural complications). The primary clinical endpoint was 12-month TLF (cardiac death, target-vessel myocardial infarction, or ischemia-driven revascularization). RESULTS: A total of 571 patients (including 595 target lesions) were included. Technical failure occurred in 60 (10.5%) of the lesions, whereas 12-month TLF was reported in 41 (7.2%) cases. Multivariable analysis identified multivessel disease (OR: 1.39; 95% CI: 1.02-1.90), in-stent lesions (OR: 1.94; 95% CI: 1.14-3.30), and the absence of intravascular imaging (OR: 1.95; 95% CI: 1.13-3.40) as independent determinants of technical failure. Left circumflex (HR: 2.97; 95% CI: 1.49-5.92), in-stent target lesions (HR: 2.01; 95% CI: 1.02-3.52), technical failure (HR: 2.42; 95% CI: 1.26-4.61), diabetes mellitus (HR: 2.35; 95% CI: 1.23-4.47), reduced estimated glomerular filtration rate (HR: 0.98; 95% CI: 0.97-0.99), and younger age (HR: 0.95; 95% CI: 0.92-0.98) emerged as factors independently associated with TLF. CONCLUSIONS: Our findings demonstrate that residual risk in IVL-assisted percutaneous coronary intervention is driven by a distinct interplay of modifiable and nonmodifiable factors, rather than inherent limitations of the technology itself.

JACC AdvancesVol. 5(8)
Cliniques Universitaires Saint-Luc (BE), University of Salento (IT), Radboud University Nijmegen (NL), Leiden University Medical Center (NL), Radboud University Medical Center (NL), Hellenic Red Cross (GR), Red Cross Hospital (GR), Staal Technisch Centrum (Netherlands) (NL), Netherlands Heart Institute (NL), Maasstad Ziekenhuis (NL), Amsterdam University Medical Centers (NL), IRCCS Humanitas Research Hospital (IT), Hippocration General Hospital (GR)
Good health and well-being
Openalex Percentile: Top 7%
Coronary Interventions and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.